Physician
Infectious Disease
Dr. Brian K. Agan, MD
Doctor Brian K. Agan, MD is an expert in the field of Infectious Disease. He graduated from University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is one of the top medical schools in the US. University of Colorado Denver School of Medicine has a rank of 35 in research and a 8 in primary care Brian Agan is also a published MD. He has 51 paper published. The most recent paper is: Toxoplasma gondii seroprevalence: 30-year trend in an HIV-infected US military cohort.
Publications
- Toxoplasma gondii seroprevalence: 30-year trend in an HIV-infected US military cohort.
- HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
- A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis.
- Inference for Surrogate Endpoint Validation in the Binary Case.
- HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers after CART Initiation among HIV-Infected Adults.
- Influence of the Timing of Antiretroviral Therapy on the Potential for Normalization of Immune Status in Human Immunodeficiency Virus 1-Infected Individuals.
- HIV outcomes in Hepatitis B virus coinfected individuals on HAART.
- Reply to Tsai et al.
- Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.
- Reply to Gamaldo and McArthur.
- Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons.
- Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uni...
- Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.
- Early Post-Seroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1-Postive Subjects Receiving Antiretroviral Therapy.
- Medical encounter characteristics of HIV seroconverters in the US Army and Air Force, 2000â2004.
- The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.
- Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
- Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience.
- Are HIV-positive persons progressing faster after diagnosis over the epidemic?
- HIV infection among U.S. Army and Air Force military personnel: sociodemographic and genotyping analysis.
- CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
- The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults.
- Cutaneous malignancies among HIV-infected persons.
- Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced...
- Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.
- Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
- Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART.
- Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.
- Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations.
- Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.
- CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
- CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.
- HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
- Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.
- CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
- New-onset seizures.
- Sensitivity of the Multispot HIV-1/HIV-2 rapid test using samples from human immunodeficiency virus type 1-positive individuals with various levels of exposure to high...
- Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays.
- Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
- The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
- Potential use of microarray technology for rapid identification of central nervous system pathogens.
- Pulmonary hemorrhage syndrome associated with an autochthonous case of dengue hemorrhagic fever.
- Laboratory diagnosis of Bartonella infections.
- Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia.
- Hepatitis B Vaccine Responsiveness and Clinical Outcomes in HIV Controllers.
- HIV Infection, Antiretroviral Therapy Initiation and Longitudinal Changes in Biomarkers of Organ Function.
- Race/ethnicity and HAART initiation in a military HIV infected cohort.
- Combining Epidemiologic and Biostatistical Tools to Enhance Variable Selection in HIV Cohort Analyses.
- Delayed-type hypersensitivity (DTH) test anergy does not impact CD4 reconstitution or normalization of DTH responses during antiretroviral therapy.
- A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS).
Schools
UNIVERSITY OF COLORADO AT DENVER
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
San Antonio Uniformed Services Health Education Consortium -
University of Colorado Denver School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Anita Kohli, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John I. Gallin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Helene F. Rosenberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John R. Mascola, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Philip E. Coyne Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Koup, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Steven M. Holland, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jeffrey I. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yingda L. Xie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey P. Nadler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Trevor A. Crowell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naomi E. Aronson, MD |
|
|
Dr. Laurence B. Balter, MD
This Doctor is OpenDoctor Recommended.
|